Every article, report, and earnings note where GEHC appears.
GE HealthCare Technologies Inc. (GEHC) climbs after a detailed earnings beat, with EPS and revenue topping estimates, orders and backlog hitting records, and imaging and pharmaceutical diagnostics offsetting weakness in Patient Care Solutions. The full analysis looks beyond the headline move to segment trends, margins, and the turnaround path ahead.
GE HealthCare offers a credible Buy case built on recurring service revenue, diagnostics, and a broad global installed base. Upside is supported by cash generation and innovation, but earnings volatility and leverage keep the story from being low risk.
GE HealthCare Technologies Inc. (GEHC) climbs 12.0% after reporting earnings beats, as investors react to stronger-than-expected results and improved outlook.
GE HealthCare Technologies Inc. (GEHC) falls after a closer look at earnings shows a profit miss, margin pressure, and a lowered full-year outlook despite solid revenue and backlog growth. This deep-dive analysis breaks down segment performance, inflation headwinds, and why investors focused on guidance rather than sales.
GE HealthCare Technologies Inc. (GEHC) falls sharply after its first-quarter report missed profit estimates and management cut full-year guidance. Revenue beat expectations, but inflationary cost pressure and weaker profit outlook overshadowed the top-line strength, triggering heavy selling on above-average volume.
GE HealthCare Technologies Inc. (GEHC) falls 13.8% after reporting an earnings miss, as investors react to weaker-than-expected results and pressure on the stock.
Generate an AI-powered research report — grades, price targets, financials, and chart analysis on demand.
Generate GEHC ReportCancel anytime